Cholesterol supplementation does not improve developmental progress in Smith-Lemli-Opitz syndrome
- 30 June 2004
- journal article
- clinical trial
- Published by Elsevier in The Journal of Pediatrics
- Vol. 144 (6) , 783-791
- https://doi.org/10.1016/j.jpeds.2004.02.036
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Incidence of Smith-Lemli-Opitz syndrome in Ontario, CanadaAmerican Journal of Medical Genetics, 2001
- Behavior phenotype in the RSH/Smith-Lemli-Opitz syndromeAmerican Journal of Medical Genetics, 2001
- Role of cholesterol in embryonic developmentThe American Journal of Clinical Nutrition, 2000
- The Smith-Lemli-Opitz syndromeJournal of Medical Genetics, 2000
- Behavioral phenotype of RSH/Smith-Lemli-Opitz syndromeMental Retardation and Developmental Disabilities Research Reviews, 2000
- Relationship between abnormal cholesterol synthesis and retarded learning in ratsMetabolism, 1998
- Clinical and biochemical spectrum of patients with RSH/Smith-Lemli-Opitz syndrome and abnormal cholesterol metabolismAmerican Journal of Medical Genetics, 1997
- Defective Cholesterol Biosynthesis Associated with the Smith-Lemli-Opitz SyndromeNew England Journal of Medicine, 1994
- Defective cholesterol biosynthesis in Smith-Lemli-Opitz syndromeThe Lancet, 1993
- A newly recognized syndromeof multiple congenital anomaliesThe Journal of Pediatrics, 1964